Solutions: Extend trial to 6 months before concluding inefficacy (some benefits take longer), increase dosing within safe ranges if using lower end, switch peptides (try Cerebrolysin if using BPC-157, or vice versa), add comprehensive eye exam to rule out progression versus peptide failure, consider peptides preventing worsening rather than producing improvement, discontinue if truly no benefit after 6 months rigorous trial
A single B12 shot continues to deliver benefits for roughly two to four weeks, with peak effects in the first week and a gradual taper after
Treatment of HFpEF beyond the SGLT2-is: does the addition of GLP-1 RA improve cardiometabolic risk and outcomes in diabetic patients
You have a medical condition, including insulin resistance, prediabetes or Type 2 diabetes
Both drug classes have demonstrated ability to increase genioglossus muscle activity, thus preventing upper airway collapse during sleep